Closed-loop discovery platform integration is needed for artificial intelligence to make an impact in drug discovery
Semion K. Saikin, Christoph Kreisbeck, Dennis Sheberla, Jill S. Becker, Alán Aspuru‐Guzik · Expert Opinion on Drug Discovery · 2018
The development of a new drug is an expensive process with estimated costs of US $1.5 billion which can take several years, even before extensive clinical or preclinical testing [1]. Early-stage dr...